Between Dec 31, 2020, and March 16, 2022, 13·2 million vaccine doses were administered in Hong Kong's 7·4-million population. We analysed data from confirmed cases with mild or moderate (n=5566), severe or fatal (n=8875), and fatal (n=6866) COVID-19. Two doses of either vaccine protected against severe disease and death within 28 days of a positive test, with higher effectiveness among adults aged 60 years or older with BNT162b2 (vaccine effectiveness 89·3% [95% CI 86·6–91·6]) compared with CoronaVac (69·9% [64·4–74·6]). Three doses of either vaccine offered very high levels of protection against severe or fatal outcomes (97·9% [97·3–98·4]).
天大的笑话
交易时间后让我们再进行一场对事不对人的讨论
不要随便广义化。
我以地球人自居，哪个国家也不爱，哪个国家也不恨，冤枉啊
中国美国的生物医药都是做假重灾区，你的发言表明你的逻辑能力肯定有严重的bias。
你很有自知之明，取了一个傻叉ID
我生病10来天了，吃药也不见好，美国药都是骗人的。
第一句话是事实，第二句话也是事实，但是从逻辑上并不能推到第三句话是正确的。要证明第三句话是正确的，要有多得多的数据，而且是相关证据。
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext
Between Dec 31, 2020, and March 16, 2022, 13·2 million vaccine doses were administered in Hong Kong's 7·4-million population. We analysed data from confirmed cases with mild or moderate (n=5566), severe or fatal (n=8875), and fatal (n=6866) COVID-19. Two doses of either vaccine protected against severe disease and death within 28 days of a positive test, with higher effectiveness among adults aged 60 years or older with BNT162b2 (vaccine effectiveness 89·3% [95% CI 86·6–91·6]) compared with CoronaVac (69·9% [64·4–74·6]). Three doses of either vaccine offered very high levels of protection against severe or fatal outcomes (97·9% [97·3–98·4]).